Actelion Medical Writer

At Manningham Medical Centre, you can find all the data about Actelion Medical Writer. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.

Actelion - Wikipedia

https://en.wikipedia.org/wiki/Actelion

Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. Actelion focuses on the manufacture of drugs that treat rare diseases and orphan diseases. Some of the drugs it has produced have been used to treat … See more

Actelion (now Janssen Pulmonary …

https://www.linkedin.com/company/actelion-%27now-janssen-pulmonary-hypertension%27

Actelion (now Janssen Pulmonary Hypertension) Pharmaceutical Manufacturing Follow View all 767 employees About us We're now part of Janssen. For …

Johnson & Johnson to Acquire Actelion for $30 Billion …

https://www.jnj.com/media-center/press-releases/johnson-johnson-to-acquire-actelion

Aligns with Janssen Pharmaceuticals’ Transformational Medical Innovation Strategy: Actelion’s PAH franchise, including differentiated, innovative medicines …

Actelion Medical Information | UPTRAVI® (selexipag) HCP

https://www.uptravihcp.com/actelion-medical-information-contact/

Please call: 1-800-JANSSEN (1-800-526-7736) Monday-Friday, 9 am - 8 pm ET. MAIL If you prefer to correspond with us via regular mail, or have inquiries regarding vendor …

Actelion | Company Overview & News - Forbes

https://www.forbes.com/companies/actelion/

Actelion Ltd. operates as a holding company with interests in developing, producing and marketing pharmaceutical …

Actelion Pulls Requests to Treat Inoperable CTEPH with …

https://pulmonaryhypertensionnews.com/news/actelion-pulls-requests-opsumit-for-inoperable-cteph-gathering-more-clinical-data/

Actelion’s filings to extend Opsumit’s use for inoperable CTEPH relied on data from the Phase 2 clinical trial MERIT-1 ( NCT02021292 ), which evaluated the …

Actelion Pharmaceuticals Agrees to Pay $360 Million to …

https://www.justice.gov/usao-ma/pr/actelion-pharmaceuticals-agrees-pay-360-million-resolve-allegations-it-paid-kickbacks

Actelion Pharmaceuticals Agrees to Pay $360 Million to Resolve Allegations that it Paid Kickbacks Through a Co-Pay Assistance Foundation. BOSTON – The U.S. …

macitentan - PMLiVE

https://www.pmlive.com/tags/macitentan?tag=bWFjaXRlbnRhbg==&cachebuster=1598692723

J&J abandons talks with Actelion as another suitor circles for follow-up PAH drugs Opsumit (macitentan) and Uptravi (selexipag), which are predicted to bring in combined sales of …

Drug Maker Actelion Agrees to Pay $360 Million to …

https://www.justice.gov/opa/pr/drug-maker-actelion-agrees-pay-360-million-resolve-false-claims-act-liability-paying

Pharmaceutical company Actelion Pharmaceuticals US, Inc. (Actelion), based in South San Francisco, California, has agreed to pay $360 million to resolve …

Medical Science Liaison Field Director, PH North Region

https://www.linkedin.com/jobs/view/medical-science-liaison-field-director-ph-north-region-at-johnson-johnson-3483542955

Minimum of 8 years experience required; 4-5 years of pharmaceutical industry, clinical/research experience is required and 2-3 years of MSL experience is required. TA …

Need more information about Actelion Medical Writer?

At Manningham Medical Centre, we collected data on more than just Actelion Medical Writer. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.